Clinical and morphologic spectrum of renal involvement in patients with HBV-associated cryoglobulinaemia

Nephrology

Volumn 22, Issue 6, 2017, Pages 449-455

  Li, Shi Jun ^a   Xu, Shu Tian ^a   Chen, Hui Ping ^a   Zhang, Ming Chao ^a   Xu, Feng ^a   Cheng, Shui Qin ^a   Liu, Zhi Hong ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

cryoglobulinaemia; glomerulonephritis; hepatitis B virus infection

Indexed keywords

CORTICOSTEROID; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; ENTECAVIR; LAMIVUDINE; MYCOPHENOLATE MOFETIL; PREDNISOLONE; RHEUMATOID FACTOR; RITUXIMAB; VIRUS ANTIGEN; ANTIVIRUS AGENT; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CRYOGLOBULINEMIA; DISEASE CLASSIFICATION; END STAGE RENAL DISEASE; FEMALE; HEMATURIA; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; HYPOCOMPLEMENTEMIA; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TISSUE; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MIDDLE AGED; MONOTHERAPY; NEPHROTIC SYNDROME; PLASMA EXCHANGE; PROTEINURIA; PURPURIC RASH; REMISSION; RETROSPECTIVE STUDY; COMPLICATION; GLOMERULONEPHRITIS; OUTCOME ASSESSMENT; PATHOLOGY; VIROLOGY;

ADULT; AGED; ANTIVIRAL AGENTS; CRYOGLOBULINEMIA; FEMALE; GLOMERULONEPHRITIS; HEPATITIS B; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES;

EID: 85018757398     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12795     Document Type: Article

References (22)

1. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet 2012; 379 (9813): 348–60.
2. Ferri C, Greco F, Longombardo G et al. Association between hepatitis C virus and mixed cryoglobulinemia. Clin. Exp. Rheumatol. 1991; 9: 621–4.
3. Fabrizi F, Plaisier E, Saadoun D, Martin P, Messa P, Cacoub P. Hepatitis C virus infection, mixed cryoglobulinemia and kidney disease. Am. J. Kidney Dis. 2013; 61: 623–37.
4. D_Amico G. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int. 1998; 54: 650–71.
5. Beddhu S, Bastacky S, Johnson JP. The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 2002; 81: 398–409.
6. Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China. J. Gastroenterol. Hepatol. 2013; 28 (1): 7–10.
7. Liang X, Bi S, Yang W et al. Epidemiological serosurvey of hepatitis B in China—declining HBV prevalence due to hepatitis B vaccination. Vaccine 2009; 27: 6550–7.
8. Levo Y, Gorevic P, Kassab H, Zucker-Franklin D, Frankin E. Association between hepatitis B virus and essential mixed cryoglobulinemia. N. Engl. J. Med. 1977; 296: 1501–4.
9. Trejo O, Ramos-Casals M, García-Carrasco M et al. Cryoglobulinemia. Study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 2001; 80: 252–62.
10. Enríquez R, Sirvent AE, Andrada E et al. Cryoglobulinemic glomerulonephritis in chronic hepatitis B infection. Ren. Fail. 2010; 32: 518–22.
11. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am. J. Med. 1974; 57: 775–88.
12. Cacoub P, Saadoun D, Bourlière M et al. Hepatitis B virus genotypes and extrahepatic manifestations. J. Hepatol. 2005; 43: 764–70.
13. Ferri C, Sebastiani M, Giuggioli D et al. Mixed cryoglobulinemia: Demographic, clinical and serologic features and survival in 231 patients. Semin. Arthritis Rheum. 2004; 33: 355–74.
14. Boglione L, D'Avolio A, Cariti G, Di Perri G. Telbivudine in the treatment of hepatitis B-associated cryoglobulinemia. J. Clin. Virol. 2013; 56: 167–9.
15. Cacoub P, Fabiani FL, Musset L et al. Mixed cryoglobulinemia and hepatitis C virus. Am. J. Med. 1994; 96: 124–32.
16. Roccatello D, Fornasieri A, Giachino O et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am. J. Kidney Dis. 2007; 49: 69–82.
17. Tedeschi A, Baratè C, Minola E, Morra E. Cryoglobulinemia. Blood Rev. 2007; 21: 183–200.
18. Anand A, Krishna GG, Sibley RK, Kambham N. Sjögren Syndrome and Cryoglobulinemic Glomerulonephritis. Am. J. Kidney Dis. 2015; 66: 532–5.
19. Yamazaki T, Akimoto T, Okuda K et al. Kusano E: Purpura with ulcerative skin lesions and mixed cryoglobulinemia in a quiescent hepatitis B virus carrier. Intern. Med. 2014; 53: 115–19.
20. Viganò M, Martin P, Cappelletti M, Fabrizi F. HBV-associated cryoglobulinemic vasculitis: remission after antiviral therapy with entecavir. Kidney Blood Press. Res. 2014; 39: 65–73.
21. De Vita S, Quartuccio L, Isola M et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum. 2012; 64: 843–53.
22. Pasquet F, Combarnous F, Macgregor B et al. Safety and efficacy of rituximab treatment for vasculitis in hepatitis B virus-associated type II cryoglobulinemia: a case report. J Med Case Rep. 2012; 6: 39.